Skip to main content
logo
Pyxis Oncology logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.030
+0.040 (2.01%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Pyxis Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-88.73-79.62-77.33-73.79-120.72-75.98
Depreciation & Amortization
4.184.512.981.930.710.65
Asset Writedown & Restructuring Costs
--20.96-9.2820
Loss (Gain) From Sale of Investments
-1.34-2.96-6.11-4.79--
Loss (Gain) on Equity Investments
-----0.05
Stock-Based Compensation
11.8911.812.9516.9515.766.44
Other Operating Activities
0.90.820.70.661.136.84
Change in Accounts Payable
-6.146.031.2-3.51-8.334.64
Change in Unearned Revenue
---7.661--
Change in Other Net Operating Assets
8.33-4.08-3.2-9.1612.832.03
Operating Cash Flow
-67.91-63.5-57.67-70.71-89.34-35.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0.24-6.73-6.4-0.54
Cash Acquisitions
---6.66--
Investment in Securities
65.4158.878.39-104.78--0.05
Investing Cash Flow
65.458.868.16-104.85-6.4-0.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
10.790.7451.876.370.18152.46
Repurchase of Common Stock
-0.16-0.15-0.24-0.45--
Other Financing Activities
--7.7---
Financing Cash Flow
10.630.5959.335.930.18304.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
8.12-4.059.81-169.63-95.55268.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-67.92-63.51-57.91-77.44-95.73-35.87
Free Cash Flow Growth
------
Free Cash Flow Margin
-615.32%-458.30%-358.66%---
Free Cash Flow Per Share
-1.07-1.02-0.99-1.94-2.90-4.22
Levered Free Cash Flow
-23.19-31.38-33.79-43.21-57.39-25.47
Unlevered Free Cash Flow
-23.19-31.38-33.79-43.21-57.39-25.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.090.090.010--
Cash Income Tax Paid
1.381.380.160.050.02-
Change in Working Capital
5.181.94-11.82-11.664.56.68
SEC Filings: 10-K · 10-Q